VivoSeq
Other

Wound Infection

0

Pipeline Programs

0

Active Trials

2

Companies Involved

Wound Infection is an early-stage landscape with 0 programs across 2 companies. The most active players are Precisio Biotix Therapeutics, Inc., MolecuLight Inc..

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed11 · 79%
Unknown status3 · 21%

Trial Activity

14 trials

Reduction of Postoperative Wound Infections by Antiseptica?
Completed··Phase 3·NCT04055233·456 enrolled
Wound Infections Following Implant Removal
Completed··Phase 4·NCT02225821·500 enrolled
To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection Rates
Unknown status··Phase 4·NCT04917627·500 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)